BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3286444)

  • 21. Two mutant forms of human insulin. Structural consequences of the substitution of invariant B24- or B25-phenylalanine by leucine.
    Wollmer A; Strassburger W; Glatter U; Dodson GG; McCall M; Gattner HG; Danho W; Brandenburg D; Rittel W
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):581-91. PubMed ID: 7024084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulin gene and abnormal insulinemia].
    Doi K
    Nihon Rinsho; 1989 Nov; 47(11):2604-11. PubMed ID: 2689694
    [No Abstract]   [Full Text] [Related]  

  • 23. Lilly lecture 1983. Abnormal products of the human insulin gene.
    Tager HS
    Diabetes; 1984 Jul; 33(7):693-9. PubMed ID: 6376225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of insulin variants in patients with hyperinsulinemia by reversed-phase, high-performance liquid chromatography.
    Seino S; Funakoshi A; Fu ZZ; Vinik A
    Diabetes; 1985 Jan; 34(1):1-7. PubMed ID: 3880547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reverse phase high performance liquid chromatographic analysis of circulating insulin in the insulin autoimmune syndrome.
    Wasada T; Eguchi Y; Takayama S; Yao KS; Hirata Y
    J Clin Endocrinol Metab; 1988 Jan; 66(1):153-8. PubMed ID: 3275683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Insulin gene and its abnormality].
    Kobayashi M
    Nihon Naika Gakkai Zasshi; 1991 Aug; 80(8):1243-7. PubMed ID: 1919243
    [No Abstract]   [Full Text] [Related]  

  • 27. Familial hyperproinsulinaemia due to a mutation substituting histidine for arginine at position 65 in proinsulin: identification of the mutation by restriction enzyme mapping.
    Collinet M; Berthelon M; BĂ©nit P; Laborde K; Desbuquois B; Munnich A; Robert JJ
    Eur J Pediatr; 1998 Jun; 157(6):456-60. PubMed ID: 9667398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution.
    Shoelson S; Fickova M; Haneda M; Nahum A; Musso G; Kaiser ET; Rubenstein AH; Tager H
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7390-4. PubMed ID: 6424111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin gene mutation].
    Nishi M; Nanjo K
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():637-41. PubMed ID: 12238111
    [No Abstract]   [Full Text] [Related]  

  • 30. [Insulinopathy].
    Haruta T; Kobayashi M
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():573-8. PubMed ID: 9513480
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin Wakayama: familial mutant insulin syndrome in Japan.
    Nanjo K; Miyano M; Kondo M; Sanke T; Nishimura S; Miyamura K; Inouye K; Given BD; Chan SJ; Polonsky KS
    Diabetologia; 1987 Feb; 30(2):87-92. PubMed ID: 3552828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Register-shift" insulin analogs uncover constraints of proteotoxicity in protein evolution.
    Rege NK; Liu M; Dhayalan B; Chen YS; Smith NA; Rahimi L; Sun J; Guo H; Yang Y; Haataja L; Phillips NFB; Whittaker J; Smith BJ; Arvan P; Ismail-Beigi F; Weiss MA
    J Biol Chem; 2020 Mar; 295(10):3080-3098. PubMed ID: 32005662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of conformational changes in diabetes-associated mutation in insulin a chain: a molecular dynamics study.
    Kim YH; Kastner K; Abdul-Wahid B; Izaguirre JA
    Proteins; 2015 Apr; 83(4):662-9. PubMed ID: 25641314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INS-gene mutations: from genetics and beta cell biology to clinical disease.
    Liu M; Sun J; Cui J; Chen W; Guo H; Barbetti F; Arvan P
    Mol Aspects Med; 2015 Apr; 42():3-18. PubMed ID: 25542748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport.
    Liu M; Haataja L; Wright J; Wickramasinghe NP; Hua QX; Phillips NF; Barbetti F; Weiss MA; Arvan P
    PLoS One; 2010 Oct; 5(10):e13333. PubMed ID: 20948967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth.
    Liu M; Hodish I; Haataja L; Lara-Lemus R; Rajpal G; Wright J; Arvan P
    Trends Endocrinol Metab; 2010 Nov; 21(11):652-9. PubMed ID: 20724178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying genes for coronary artery disease: An idea whose time has come.
    Roberts R; Stewart AF; Wells GA; Williams KA; Kavaslar N; McPherson R
    Can J Cardiol; 2007 Aug; 23 Suppl A(Suppl A):7A-15A. PubMed ID: 17668082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular etiologies of MODY and other early-onset forms of diabetes.
    Shih DQ; Stoffel M
    Curr Diab Rep; 2002 Apr; 2(2):125-34. PubMed ID: 12643132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of beta allele of the insulin gene in type II diabetes mellitus.
    Horst-Sikorska W; Zoll B; Kwiatkowska J; Willms B; Kraszewski A; Horst A; Slomski R
    Hum Genet; 1994 Mar; 93(3):325-8. PubMed ID: 8125485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant insulin syndromes.
    Vinik A; Bell G
    Horm Metab Res; 1988 Jan; 20(1):1-10. PubMed ID: 3286444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.